Capital Analysts, LLC
- SEC CIK
- 0001624758
- Latest filing
- Aug 5, 2026
VRCA holding history
Verrica Pharmaceuticals Inc. in every 13F filed by Capital Analysts, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VRCA overviewAll 13F holders of VRCAFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,500
- Value
- $9.00K
- % of portfolio
- <0.1%
- Quarters held
- 8
- Since Q3 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,500 | $9.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 1,500 | $8.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 1,500 | $12.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 1,500 | $6.00K | <0.1% | −630−29.6% | ReducedConverted for a 1-for-10 split | Holders |
| Q2 2025 | 21,300 | $11.0K | <0.1% | +5,000+30.7% | Added | Holders |
| Q1 2025 | 16,300 | $7.00K | <0.1% | +3,000+22.6% | Added | Holders |
| Q4 2024 | 13,300 | $9.00K | <0.1% | +7,000+111.1% | Added | Holders |
| Q3 2024 | 6,300 | $9.00K | <0.1% | +6,300 | New | Holders |